From Status Iatrogenicus by Scott Aberegg, M.D., M.P.H. This would be a very informative case report (and it's true and unexaggerated), but I anticipate staunch editorial resistance (even sans puns), so I'll describe it here and have some fun with it. Background: The author has anecdotally observed for many years that so-called "septic shock" follows [... read more]
Jon-Emile S. Kenny MD [@heart_lung] In the last few weeks I have been contacted by curious clinical physiologists craving my conceptions of ‘venous excess’ . These words will address this model, concisely and – I pray – clearly. The Myth of Venous Return The roots of venous excess took hold within the fertile soil of [... read more]
The post ICU Physiology in 1000 Words: Venous Excess & the Myth of Venous Return appeared first on PulmCCM.
The US Food and Drug Administration (FDA) approved an implanted phrenic nerve-stimulator device as a new treatment for moderate-to-severe central sleep apnea (CSA). The remedē System (Respicardia) consists of a pacemaker-like battery pack that’s surgically implanted in the upper chest beneath the skin. Wires electrically stimulate the phrenic nerve as it travels from the neck [... read more]
The post FDA approves new phrenic nerve stimulator for central sleep apnea appeared first on PulmCCM.